These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18688094)

  • 1. Tau aggregates: toxic, inert, or protective species?
    Bretteville A; Planel E
    J Alzheimers Dis; 2008 Aug; 14(4):431-6. PubMed ID: 18688094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is tau aggregation toxic or protective?
    Congdon EE; Duff KE
    J Alzheimers Dis; 2008 Aug; 14(4):453-7. PubMed ID: 18688098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the toxicity of tau aggregation.
    Rankin CA; Gamblin TC
    J Alzheimers Dis; 2008 Aug; 14(4):411-6. PubMed ID: 18688091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau aggregates and tau pathology.
    Hernández F; Avila J
    J Alzheimers Dis; 2008 Aug; 14(4):449-52. PubMed ID: 18688097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    Jouanne M; Rault S; Voisin-Chiret AS
    Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Neurotoxic Role of Extracellular Tau Protein.
    Sebastián-Serrano Á; de Diego-García L; Díaz-Hernández M
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods?
    Götz J; Ittner LM; Fändrich M; Schonrock N
    J Alzheimers Dis; 2008 Aug; 14(4):423-9. PubMed ID: 18688093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau therapeutic strategies for the treatment of Alzheimer's disease.
    Churcher I
    Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The last tangle of tau.
    Ding H; Johnson GV
    J Alzheimers Dis; 2008 Aug; 14(4):441-7. PubMed ID: 18688096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
    García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tau oligomers in the onset of Alzheimer's disease neuropathology.
    Cárdenas-Aguayo Mdel C; Gómez-Virgilio L; DeRosa S; Meraz-Ríos MA
    ACS Chem Neurosci; 2014 Dec; 5(12):1178-91. PubMed ID: 25268947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p70 S6 kinase and tau in Alzheimer's disease.
    Pei JJ; Björkdahl C; Zhang H; Zhou X; Winblad B
    J Alzheimers Dis; 2008 Aug; 14(4):385-92. PubMed ID: 18688088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the pathological significance of tau oligomers?
    Cowan CM; Quraishe S; Mudher A
    Biochem Soc Trans; 2012 Aug; 40(4):693-7. PubMed ID: 22817718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease.
    Lloret A; Fuchsberger T; Giraldo E; Viña J
    Free Radic Biol Med; 2015 Jun; 83():186-91. PubMed ID: 25746773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.